SIGLEC1 and breast neoplasm: Together this suggests that CD169+ macrophages generated from monocytes in a type I IFN tumor microenvironment in vitro (CD169+ Mo-M), possess a unique phenotype, much resembling CD169+ TAMs in breast tumors and CD169+ lymph node macrophages.